A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 4 201,64 Kč, with a 24-hour trading volume of 34,77M Kč. The asset's market cap is 6,51T Kč, after moving 0.15% in the last day.
Tokenized AstraZeneca PLC is trading at 2 069,17 Kč, with a tokenized market cap of 15,51M Kč and a 24-hour trading volume of 13,37M Kč. The tokenized asset has moved -0.63% in the past 24 hours.